DexCom (DXCM) PT Raised to $150 at Piper Sandler
Tweet
Share
E-mailGet Alerts DXCM Hot Sheet
Price: $91.04 +1.61%
Rating Summary:
32 Buy, 7 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 9 | New: 13
Rating Summary:
32 Buy, 7 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 9 | New: 13
Join SI Premium – FREE
Piper Sandler analyst Matt O'Brien raised the price target on DexCom (NASDAQ: DXCM) to $150.00 (from $135.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Baidu (BIDU) PT Lowered to $150 at Benchmark on Near-Term Margin Concerns
- Morgan Stanley Downgrades Diamondback Energy (FANG) to Equalweight
- Home Depot (HD) PT Raised to $373 at Truist Securities
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
